Lexaria Receives USD$2.6 Million Tax Rebate Payment
Lexaria Bioscience received a cash rebate of AUD$3.67 million (approximately USD$2.6 million) from the Australian Tax Office related to its 2025 R&D study. The company intends to use these non-dilutive funds for future research and development plans in Australia to further validate its DehydraTECH technology.
Key figures
- Rebate amount aud
- 3,666,611.98
- Rebate amount usd
- $2.6 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.